CRMAX
Price
$10.81
Change
+$0.04 (+0.37%)
Updated
Sep 15 closing price
Net Assets
136.94M
FSMAX
Price
$100.81
Change
+$0.24 (+0.24%)
Updated
Sep 15 closing price
Net Assets
41.05B
Interact to see
Advertisement

CRMAX vs FSMAX

Header iconCRMAX vs FSMAX Comparison
Open Charts CRMAX vs FSMAXBanner chart's image
CRM Small/Mid Cap Value I
Price$10.81
Change+$0.04 (+0.37%)
VolumeN/A
Net Assets136.94M
Fidelity Extended Market Index
Price$100.81
Change+$0.24 (+0.24%)
VolumeN/A
Net Assets41.05B
CRMAX vs FSMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CRMAX vs. FSMAX commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMAX is a Hold and FSMAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41B vs. CRMAX (137M). FSMAX pays higher dividends than CRMAX: FSMAX (0.44) vs CRMAX (0.28). CRMAX was incepted earlier than FSMAX: CRMAX (21 years) vs FSMAX (14 years). CRMAX (1.21) is less costly to investors than FSMAX (0.04). CRMAX is a more actively managed with annual turnover of: 72.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than CRMAX: FSMAX (0) vs CRMAX (2500). FSMAX annual gain was more profitable for investors over the last year : 19.24 vs. CRMAX (-10.01). FSMAX return over 5 years is better than : 58.35 vs. CRMAX (1.92).
CRMAXFSMAXCRMAX / FSMAX
Total Expense Ratio1.210.043,457%
Annual Report Gross Expense Ratio1.210.043,457%
Fund Existence21 years14 years-
Gain YTD-0.55410.662-5%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets137M41B0%
Annual Yield % from dividends0.280.4464%
Returns for 1 year-10.0119.24-52%
Returns for 3 years7.0856.9012%
Returns for 5 years1.9258.353%
Returns for 10 years-18.89102.81-18%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX19.34N/A
N/A
Saratoga Health & Biotechnology A
JBAFX31.81N/A
N/A
JHancock Balanced R4
AREWX26.29N/A
N/A
American Century Real Estate R
GMZPX38.23N/A
N/A
Goldman Sachs Large Cap Gr Insghts P
BISVX14.04N/A
N/A
Brown Advisory Sustainable Val Inv